Department of Biomedical Sciences, University of Padua, Italy.
Department of Neurosciences, University of Padua, Italy.
Life Sci. 2016 May 1;152:44-51. doi: 10.1016/j.lfs.2016.03.020. Epub 2016 Mar 12.
Pulsed electromagnetic field (PEMF) therapy has been documented to be an effective, non-invasive, safe treatment method for a variety of clinical conditions, especially in settings of recalcitrant healing. The underlying mechanisms on the different biological components of tissue regeneration are still to be elucidated. The aim of the present study was to characterize the effects of extremely low frequency (ELF)-PEMFs on commitment of mesenchymal stem cell (MSCs) culture system, through the determination of gene expression pattern and cellular morphology.
Human MSCs derived from adipose tissue (ADSCs) were cultured in presence of adipogenic, osteogenic, neural, or glial differentiative medium and basal medium, then exposed to ELF-PEMFs daily stimulation for 21days. Control cultures were performed without ELF-PEMFs stimulation for all cell populations. Effects on commitment were evaluated after 21days of cultures.
The results suggested ELF-PEMFs does not influence ADSCs commitment and does not promote adipogenic, osteogenic, neural or glial differentiation. However, ELF-PEMFs treatment on ADSCs cultured in osteogenic differentiative medium markedly increased osteogenesis.
We concluded that PEMFs affect the osteogenic differentiation of ADSCs only if they are pre-commitment and that this therapy can be an appropriate candidate for treatment of conditions requiring an acceleration of repairing process.
脉冲电磁场(PEMF)疗法已被证明是一种有效的、非侵入性的、安全的治疗方法,适用于多种临床情况,尤其是在难治性愈合的情况下。组织再生的不同生物学成分的潜在机制仍有待阐明。本研究的目的是通过确定基因表达模式和细胞形态来表征极低频(ELF)-PEMF 对间充质干细胞(MSCs)培养系统的定向作用。
从脂肪组织(ADSCs)中培养的人 MSCs 分别在成脂、成骨、神经或神经胶质分化培养基和基础培养基中培养,然后每天接受 ELF-PEMF 刺激 21 天。所有细胞群体的对照培养均未进行 ELF-PEMF 刺激。在培养 21 天后评估对定向的影响。
结果表明,ELF-PEMF 不影响 ADSCs 的定向作用,也不促进成脂、成骨、神经或神经胶质分化。然而,ELF-PEMF 处理在成骨分化培养基中培养的 ADSCs 可显著增加成骨作用。
我们得出结论,只有在预先定向的情况下,PEMF 才会影响 ADSCs 的成骨分化,并且这种治疗方法可能是加速修复过程所需治疗的合适候选方法。